Skip to main content
Clinical Trials/JPRN-UMIN000014469
JPRN-UMIN000014469
Recruiting
未知

Examine the patient's response and symptom improvement using the intervention under the Integrated Approach to Symptom Management Model for the patients who has lymphedema - Effect of Integrated Approach to Symptom Management for lymphedema associated with cancer therapy (surgery/ radiation)

niversity of Hyogo0 sites20 target enrollmentJuly 14, 2014

Overview

Phase
未知
Intervention
Not specified
Conditions
lymphedema associated with cancer therapy
Sponsor
niversity of Hyogo
Enrollment
20
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 14, 2014
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
niversity of Hyogo

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\) Less than 3 months after the surgery or less than 1 month after the radiation therapy. 2\) Patients who has contraindication of lymphedema drainage therapy.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Examine the patient's response and symptom improvement using the Integrated Approach to Symptom Management Model for the patients who has oral mucositis associated with hematologic cancer therapyhematological malignancies oral mucositis associated with cancer therapy
JPRN-UMIN000016948niversity of Hyogo20
Completed
Not Applicable
Examine the patient's response and symptom improvement using the Integrated Approach to Symptom Management Model for the patients who has skin toxicity associated with molecularly targeted drugskin toxicity associated with molecularly targeted drug
JPRN-UMIN000016947niversity of Hyogo20
Active, not recruiting
Not Applicable
Pain assessment in patients with Oral Lichen Planus and Burning Mouth Syndrome during the COVID-19 pandemicichen Planus, OralBurning Mouth SyndromeD008010K14.6
RBR-62936mfFaculdade de Odontologia da Universidade de São Paulo
Completed
Not Applicable
Evaluating the response to suspected disease outbreaks using a short message service (SMS) model14 priority diseases that require immediate reporting: adverse events following immunization, anthrax, cholera, Guinea worm, measles, neonatal tetanus, plague, Rift Valley fever, severe acute respiratory infections, viral hemorrhagic fever, yellow fever, and other (any public health event of national and international concerns).Infections and Infestations
ISRCTN79529838agasaki University (Japan)153
Recruiting
Phase 2
Pathologic response, side-effects, and overall survival in cervical cancer under treatment with neo-adjuvant chemotherapy and surgerylocally advanced cervical cancer.Malignant neoplasm of cervix uteri
IRCT2017090236033N1Vice-chancellery for Research of Mashhad University of Medicla Sciences30